Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label brivaracetam adjunctive therapy in focal seizures (Japan extension)
jRCT2080223631Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2017
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of brivaracetam in Focal Onset Epilepsy and Focal onset seizure, sponsored by UCB. Primary endpoint: Long-term safety of brivaracetam. Started Aug 2017; status: completed.
02
Drugs
brivaracetam
03
Conditions
Focal Onset EpilepsyFocal onset seizure
Beyond the preview
Go deeper on jRCT2080223631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223631.